Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Oncology·MeSH: Mycosis Fungoides
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| hypericin | SOLIGENIX, INC. (SNGX) |
Phase 2(1)
| Drug | Company |
|---|---|
| mechlorethamine | SOLIGENIX, INC. (SNGX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Cutaneous T-Cell Lymphoma/Mycosis Fungoides?
BioSniper tracks 2 drugs in development for Cutaneous T-Cell Lymphoma/Mycosis Fungoides across 1 company.
How many clinical trials target Cutaneous T-Cell Lymphoma/Mycosis Fungoides?
There are 1 clinical trial targeting Cutaneous T-Cell Lymphoma/Mycosis Fungoides tracked by BioSniper.
Deep-dive into Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis